Measuring and predicting visual field progression with longitudinal-survival CART

使用纵向生存 CART 测量和预测视野进展

基本信息

  • 批准号:
    7878627
  • 负责人:
  • 金额:
    $ 18.71万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2009
  • 资助国家:
    美国
  • 起止时间:
    2009-07-01 至 2011-06-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Detection and prediction of visual field progression has been recognized as a crucially needed development for glaucoma management and care. Characterization of visual field progression will allow for directed follow-up of high risk eyes, early detection and treatment of glaucoma, better potential for slowing progression of diseased eyes, and a protocol for delaying visual field damage. As a secondary outcome, it will also provide a justifiable and valid progression outcome measure for clinical trials and studies of glaucoma. However, it is equally well recognized that characterization of progression is one of the most challenging aspects of glaucoma research and clinical evaluation but perhaps a finding with high impact on management strategies/philosophies. The primary aims of this research project are to develop clinical indicators and prognostic factors for detecting and predicting glaucomatous visual field progression. These aims will be met through applications of novel classification and regression tree (CART) methods to data from the perimetry and psychophysics in glaucoma (PPIG) study. The PPIG study consists of 168 individuals with moderate to high risk ocular hypertension or early glaucoma followed for up to eleven years with annual visual field examinations. The data includes a measure of progressive glaucomatous optic neuropathy (pGON), standard automated perimetry visual field test patterns and summaries, optic disc summaries, and other clinical and sociodemographic observations. The new CART methods developed account for correlations between fellow eyes and spatial variability in the temporal series of visual field measurements in assimilating visual field data. The CART analyses thus take full advantage of the PPIG study data in creating glaucomatous visual field progression classification systems, definitive measures for detecting visual field progression from follow-up visual fields and for predicting visual field progression from baseline observations.
描述(由申请人提供):视野进展的检测和预测已被认为是青光眼管理和护理的关键发展。视野进展的特征将允许高风险眼睛的直接随访,早期发现和治疗青光眼,更好地减缓患病眼睛的进展,以及延迟视野损害的协议。作为次要结局,它也将为青光眼的临床试验和研究提供一个合理和有效的进展结局指标。然而,同样公认的是,进展特征是青光眼研究和临床评估中最具挑战性的方面之一,但可能是对管理策略/理念具有重要影响的发现。本研究项目的主要目的是发展临床指标和预后因素,以检测和预测青光眼的视野进展。这些目标将通过应用新的分类和回归树(CART)方法来处理青光眼(PPIG)研究的视野和心理物理学数据。PPIG研究包括168名中度至高风险高眼压或早期青光眼患者,随访长达11年,每年进行视野检查。数据包括进行性青光眼视神经病变(pGON)的测量,标准的自动视野测试模式和总结,视盘总结,以及其他临床和社会人口学观察。新的CART方法在吸收视野数据时考虑了同伴眼睛与视野测量时间序列中的空间变异性之间的相关性。CART分析因此充分利用了PPIG研究数据来创建青光眼视野进展分类系统,从随访视野中检测视野进展的明确措施以及从基线观察中预测视野进展。

项目成果

期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Frailty Modeling via the Empirical Bayes Hastings Sampler.
通过经验贝叶斯黑斯廷斯采样器进行脆弱性建模。
  • DOI:
    10.1016/j.csda.2011.09.004
  • 发表时间:
    2012
  • 期刊:
  • 影响因子:
    1.8
  • 作者:
    Levine,RichardA;Fan,Juanjuan;Strickland,PamelaOhman;Demirel,Shaban
  • 通讯作者:
    Demirel,Shaban
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

RICHARD A LEVINE其他文献

RICHARD A LEVINE的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('RICHARD A LEVINE', 18)}}的其他基金

Measuring and predicting visual field progression with longitudinal-survival CART
使用纵向生存 CART 测量和预测视野进展
  • 批准号:
    7738773
  • 财政年份:
    2009
  • 资助金额:
    $ 18.71万
  • 项目类别:
Conference--6th Meeting of New Researchers in Statistics
会议--第六届统计学新学者会议
  • 批准号:
    6664721
  • 财政年份:
    2003
  • 资助金额:
    $ 18.71万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 18.71万
  • 项目类别:
    Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 18.71万
  • 项目类别:
    Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 18.71万
  • 项目类别:
    Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 18.71万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 18.71万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 18.71万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 18.71万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 18.71万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 18.71万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 18.71万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了